WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical achieves profitability on an adjusted EBITDA basis for the full-year 2024, the first time in the Company's history.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will showcase its hemodialysis concentrates portfolio at DialysisTechConneXion42 on April 1-4, 2025 in Las Vegas, NV in Booth #112.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced that it has been certified as a Great Place to Work for the third year in a row.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the fourth quarter and full-year ended December 31, 2024 on Thursday, March 20, 2025.
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical adds a 510k approved single-use bicarbonate cartridge--in two sizes, 720g and 900g--to its hemodialysis concentrates portfolio.
Incumbent Board has Destroyed Stockholder Value and Imperiled AIM's Future through Breaches of Fiduciary Duty and Bad Faith Actions
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.